Tiquel, Lira .
HRN: 12-91-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
CEFUROXIME 500MG (TAB)
01/14/2023
01/21/2023
ORAL
1 Tab
BID
S/P NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes